SMTL ID : 5e8a.1

Crystal structure of Human galectin-3 CRD in complex with 4-fluophenyl-1,2,3-triazolyl thiodigalactoside inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 3 residues within 4Å: Chain A: V.114, K.115, K.116 Ligand excluded by PLIP

1 x 5KS: 3-deoxy-3-[4-(4-fluorophenyl)-1H-1,2,3-triazol-1-yl]-beta-D-galactopyranosyl 3-deoxy-3-[4-(4-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-beta-D-galactopyranoside(Non-covalent)

5KS.2: 11 residues within 4Å: Chain A: R.33, A.35, H.47, N.49, R.51, N.63, W.70, E.73, R.75, S.126, G.127 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:R.33, A:A.35 Hydrogen bonds: A:H.47, A:R.51, A:R.51, A:N.63, A:R.75 Water bridges: A:R.33, A:R.75 pi-Stacking: A:H.47 pi-Cation interactions: A:R.33, A:R.75

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Delaine, T. et al., Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition. Chembiochem (2016)

Release Date

2016-08-24

Peptides

Galectin-3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Galectin-3

Related Entries With Identical Sequence